Skip navigation

Merro Pharmaceutical Co. Ltd.

2016 Revenue (US$ Millions)$19,502
Revenue Growth (%)44.53%
Net Income (US$ Millions)$404
Earnings Per Share (US$)$0.07
EPS Growth Rate (%)29.37%
Profit Margin2.07%
Total Equity (US$ Millions)$3,394
Return on Equity (%)13.36%
Long Term Debt (US$ Millions)$2,389
Debt To Equity Ratio (%)0.70%
Total Assets (US$ Millions)$16,123
Current Assets (US$ Millions)$9,162
Current Liabilities (US$ Millions)$9,256
Cost of Goods Sold (US$ Millions)$17,777
Inventory Turnover8.41